# Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation

> **NCT00768729** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 7 (actual)

## Conditions studied

- Kidney Failure, Chronic
- Kidney Transplantation
- Immunosuppression

## Interventions

- **DRUG:** Sirolimus
- **DRUG:** MMF or Azathioprine

## Key facts

- **NCT ID:** NCT00768729
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2013-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00768729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00768729, "Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00768729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*